4th March 2025
Chemring Group PLC
("Chemring" or the "Company")
Transaction in Own Shares
Chemring Group PLC ("Chemring" or the "Company") announces it has purchased the following number of its ordinary shares of 1 pence each through Investec Bank plc.
Ordinary Shares
| Date of purchase: | 3rd March 2025 |
| Number of ordinary shares purchased: | 20,883 |
| Lowest price per share (pence): | 380.50 |
| Highest price per share (pence): | 390.00 |
| Weighted average price per day (pence): | 386.4270 |
The Company intends to cancel the purchased shares.
The table below contains detailed information about the purchases made as part of the buyback programme which was announced by the Company on 26 February 2025 (the "Programme").
Aggregate information:
| Venue | Volume-weighted average price (p) | Aggregated volume | Lowest price per share (p) | Highest price per share (p) |
| XLON | 386.4270 | 20,883 | 380.50 | 390.00 |
Schedule of Purchases - Individual Transactions
In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 as it forms part of UK law, a full breakdown of the individual trades made by Investec on behalf of the Company as part of the Programme is detailed below:
| Date and time of each trade | Number of shares purchased | Price (pence per share) | Trading Venue | Transaction Reference Number |
| 03 March 2025 08:16:04 | 492 | 390.00 | XLON | 00325283539TRLO1 |
| 03 March 2025 08:18:07 | 465 | 390.00 | XLON | 00325284655TRLO1 |
| 03 March 2025 08:34:00 | 520 | 390.00 | XLON | 00325294495TRLO1 |
| 03 March 2025 08:39:48 | 515 | 390.00 | XLON | 00325297938TRLO1 |
| 03 March 2025 08:41:25 | 540 | 389.50 | XLON | 00325298942TRLO1 |
| 03 March 2025 08:48:59 | 507 | 389.50 | XLON | 00325302950TRLO1 |
| 03 March 2025 08:57:00 | 521 | 387.00 | XLON | 00325307180TRLO1 |
| 03 March 2025 09:03:32 | 998 | 387.50 | XLON | 00325311539TRLO1 |
| 03 March 2025 09:07:21 | 527 | 387.50 | XLON | 00325313882TRLO1 |
| 03 March 2025 09:15:52 | 499 | 389.00 | XLON | 00325318520TRLO1 |
| 03 March 2025 09:22:36 | 493 | 386.00 | XLON | 00325322073TRLO1 |
| 03 March 2025 09:32:56 | 510 | 387.00 | XLON | 00325330916TRLO1 |
| 03 March 2025 09:35:35 | 510 | 386.00 | XLON | 00325332614TRLO1 |
| 03 March 2025 09:36:59 | 499 | 385.00 | XLON | 00325333704TRLO1 |
| 03 March 2025 09:47:40 | 502 | 384.00 | XLON | 00325340947TRLO1 |
| 03 March 2025 10:00:52 | 731 | 385.00 | XLON | 00325346233TRLO1 |
| 03 March 2025 10:00:52 | 302 | 385.00 | XLON | 00325346234TRLO1 |
| 03 March 2025 10:01:23 | 508 | 384.50 | XLON | 00325346248TRLO1 |
| 03 March 2025 10:01:23 | 507 | 384.50 | XLON | 00325346249TRLO1 |
| 03 March 2025 10:09:14 | 496 | 381.00 | XLON | 00325346551TRLO1 |
| 03 March 2025 10:09:35 | 508 | 381.00 | XLON | 00325346559TRLO1 |
| 03 March 2025 10:30:30 | 987 | 383.50 | XLON | 00325347245TRLO1 |
| 03 March 2025 10:41:32 | 1,004 | 383.50 | XLON | 00325348663TRLO1 |
| 03 March 2025 10:41:37 | 493 | 383.00 | XLON | 00325348664TRLO1 |
| 03 March 2025 10:45:45 | 500 | 381.00 | XLON | 00325348853TRLO1 |
| 03 March 2025 10:48:13 | 527 | 380.50 | XLON | 00325349041TRLO1 |
| 03 March 2025 11:16:22 | 1,562 | 385.50 | XLON | 00325350393TRLO1 |
| 03 March 2025 11:29:36 | 1,582 | 388.00 | XLON | 00325350836TRLO1 |
| 03 March 2025 11:35:03 | 507 | 388.50 | XLON | 00325351098TRLO1 |
| 03 March 2025 11:48:20 | 154 | 389.50 | XLON | 00325351695TRLO1 |
| 03 March 2025 11:48:20 | 909 | 389.50 | XLON | 00325351696TRLO1 |
| 03 March 2025 12:09:23 | 986 | 390.00 | XLON | 00325352650TRLO1 |
| 03 March 2025 12:10:51 | 522 | 390.00 | XLON | 00325352738TRLO1 |
For further information:
| Rupert Pittman | Group Director of Corporate Affairs, Chemring Group PLC | +44 (0) 1794 463401 |
| James McFarlane | MHP Communications | +44 (0) 20 3128 8100 |
| Ollie Hoare | | |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
